祖拉诺用于治疗严重抑郁症:系统性审查和元分析
Abdullah Ahmad1, Abdul Rafeh Awan2, Natasha Nadeem1
1CMH Lahore Medical College, National University of Medical Sciences, Lahore, Pakistan.
Frontiers in neuroscience
|May 10, 2024
概括
祖拉诺在14天内在治疗主要抑郁症 (MDD) 中表现出显著的疗效,与安慰剂相比,抑郁症和焦虑症症状有所改善. 虽然短期单独治疗通常是安全的,但需要进一步的研究来证实长期的影响.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 大型抑郁症 (MDD) 治疗的疗效和副作用各不相同.
- 祖拉诺 (SAGE-217) 是一种新兴的抗抑郁药选择,用于MDD,产后抑郁症和基本震.
- 研究新型,耐受良好,短期单一疗法对于改善MDD管理至关重要.
研究的目的:
- 评估与安慰剂相比Zuranolone在重大抑郁症 (MDD) 治疗中的疗效和安全性.
- 综合了Zuranolone对抑郁和焦虑症状得分和不良事件的影响的现有数据.
主要方法:
- 一个系统的审查和对4项临床试验的元分析,比较Zuranolone与MDD患者的安慰剂.
- 从PubMed和Scopus获取到2023年7月的数据,分析汉密尔顿抑郁症评分表 (HAM-D),HAM-A和MADRS分数.
- 对治疗出现的不良事件 (TEAE) 和严重不良事件的评估.
主要成果:
- 与安慰剂相比,祖兰在第15天显著改善了HAM-D,MADRS和HAM-A得分 (p<0.05).
- 在祖拉诺隆组观察到更高的反应和缓解率 (p<0.01).
- 祖拉诺与TEAE的发病率较高有关,但与药物停用或严重不良事件无关.
结论:
- 祖拉诺作为MDD的有效和安全的短期单疗法,具有迅速开始作用和抗焦虑效应.
- 目前的分析仅限于小样本规模和有限数量的试验,排除了长期安全性和有效性评估.
- 需要进一步进行广泛的临床试验,以充分阐明祖拉诺在MDD治疗中的长期特征.
更多相关视频
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
666
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
504
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
01:25Antidepressant Drugs: Overview
453
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
453
01:18Depression: Overview
241
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
241
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:26Anxiolytic Drugs: Overview
279
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
279
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
375
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
375